Aitor Bergara

This study shows that ARC acts as a retroviral-like capsid for TDP-43 spreading in ALS and FTD, and that Lenacapavir blocks this process.

This study uses computational methods to analyze ELOVL6 structure and inhibition, identifying key residues and binding pathways for drug design.

This study visualizes Trigger Factor dynamics on translating ribosomes using high-speed atomic force microscopy and molecular dynamics simulations, revealing its structural flexibility and selective association with active ribosomes.